Your browser doesn't support javascript.
loading
Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19.
Allais, Christophe; Bernhardson, David; Brown, Adam R; Chinigo, Gary M; Desrosiers, Jean-Nicolas; DiRico, Kenneth J; Hotham, Ian; Jones, Brian P; Kulkarni, Samir A; Lewis, Chad A; Lira, Ricardo; Loach, Richard P; Morse, Peter D; Mousseau, James J; Perry, Matthew A; Peng, Zhihui; Place, David W; Rane, Anil M; Samp, Lacey; Singer, Robert A; Wang, Zheng; Weisenburger, Gerald A; Yayla, Hatice G; Zanghi, Joseph M.
Affiliation
  • Allais C; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Bernhardson D; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Brown AR; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Chinigo GM; Medicine Design, Pfizer Inc., Groton, Connecticut06340, United States.
  • Desrosiers JN; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • DiRico KJ; Medicine Design, Pfizer Inc., Groton, Connecticut06340, United States.
  • Hotham I; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Jones BP; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Kulkarni SA; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Lewis CA; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Lira R; Medicine Design, Pfizer Inc., Groton, Connecticut06340, United States.
  • Loach RP; Medicine Design, Pfizer Inc., Groton, Connecticut06340, United States.
  • Morse PD; Medicine Design, Pfizer Inc., Groton, Connecticut06340, United States.
  • Mousseau JJ; Medicine Design, Pfizer Inc., Groton, Connecticut06340, United States.
  • Perry MA; Medicine Design, Pfizer Inc., Groton, Connecticut06340, United States.
  • Peng Z; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Place DW; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Rane AM; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Samp L; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Singer RA; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Wang Z; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Weisenburger GA; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
  • Yayla HG; Medicine Design, Pfizer Inc., Groton, Connecticut06340, United States.
  • Zanghi JM; Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States.
Org Process Res Dev ; 2023 Feb 03.
Article in En | MEDLINE | ID: mdl-37552749
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Org Process Res Dev Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Org Process Res Dev Year: 2023 Document type: Article Affiliation country: Country of publication: